It is not uncommon for DME suppliers and sleep labs to work together in the provision of therapeutic equipment to patients who test positive for OSA.

Medtrade exhibitor Fisher & Paykel Healthcare Corp has launched the F&P my820 System into the United States.

VGM Sleep Services has earned accreditation from the Healthcare Quality Association on Accreditation (HQAA).

One meta-study found mortality was 37% lower on average in patients with PAP-treated OSA vs untreated OSA.

With a $1.1 billion settlement reached, the DreamStation difficulties may finally be over for Philips Respironics.

Medtrade exhibitor ResMed recently launched its AirCurve 11 series devices.